Literature DB >> 10226077

Transcriptional regulation of the interleukin-1beta promoter via fibrinogen engagement of the CD18 integrin receptor.

R L Perez1, J D Ritzenthaler, J Roman.   

Abstract

Fibrinogen, with or without its conversion to fibrin, in the extravascular spaces of injured and inflamed lung tissues is thought to promote inflammatory responses that can eventually lead to pulmonary fibrosis. One of these responses likely involves the elaboration of the proinflammatory cytokine interleukin (IL)- 1beta. We reported that both fibrinogen and fibrin stimulated production of IL-1beta message and protein by binding to CD18 integrin receptors on normal human monocytes (J. Immunol., 1995;154:1879-1887). The purpose of the current work was to extend our previous observations by characterizing the transcriptional regulation of fibrinogen-induced IL-1beta expression. Our model was the human monocytic cell line U937 transfected with the human IL-1beta promoter connected to reporter genes. We found that fibrinogen induced the IL-1beta promoter and that induction could be blocked by anti-CD18 antibody. Transfection with deletion constructs of the promoter and DNA electrophoresis mobility gel shift assays suggested that sequences containing activator protein (AP)-1, cyclic adenosine monophosphate response element (CRE), and nuclear factor (NF)-kappaB cis-acting motifs regulate IL-1beta gene expression by fibrinogen. In combination with competitive cotransfection studies using consensus oligonucleotides mimicking these motifs, we conclude that transactivation of an NF-kappaB-like sequence is necessary for induction of the IL-1beta gene, that activation of CRE may repress induction of the gene, and that AP-1 potentially modulates induction and repression of the gene induced by fibrinogen. This study begins to define the molecular mechanisms by which fibrin(ogen) promotes and regulates expression of the IL-1beta gene and further substantiates a role for fibrin(ogen) in tissue injury and inflammation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226077     DOI: 10.1165/ajrcmb.20.5.3281

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  28 in total

1.  Differential modes of regulation of interleukin-1beta expression by extracellular matrices.

Authors:  J Roman; J D Ritzenthaler; R L Perez; S L Roser
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

2.  Plasmin deficiency leads to fibrin accumulation and a compromised inflammatory response in the mouse brain.

Authors:  K Hultman; M Cortes-Canteli; A Bounoutas; A T Richards; S Strickland; E H Norris
Journal:  J Thromb Haemost       Date:  2014-05       Impact factor: 5.824

Review 3.  Fibrinogen as a key regulator of inflammation in disease.

Authors:  Dimitrios Davalos; Katerina Akassoglou
Journal:  Semin Immunopathol       Date:  2011-10-31       Impact factor: 9.623

4.  Hyperfibrinogenemia in appendicitis: a new predictor of perforation in children.

Authors:  Shaoguang Feng; Peng Wu; Xiaoming Chen
Journal:  Pediatr Surg Int       Date:  2014-08-13       Impact factor: 1.827

5.  Aggregates of denatured proteins stimulate nitric oxide and superoxide production in macrophages.

Authors:  Szczepan Jozefowski; Janusz Marcinkiewicz
Journal:  Inflamm Res       Date:  2009-09-26       Impact factor: 4.575

6.  Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.

Authors:  Ya Zhang; Xiaomei Zhang; Dongsheng Liu; Honghao Wang; Suyue Pan; Dongmei Wang; Xiong Chen
Journal:  Neurol Sci       Date:  2016-07-23       Impact factor: 3.307

7.  Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS).

Authors:  Malgorzata Wygrecka; Philipp Markart; Ludger Fink; Andreas Guenther; Klaus T Preissner
Journal:  Thorax       Date:  2007-05-04       Impact factor: 9.139

8.  Dibutyltin-induced alterations of interleukin 1beta secretion from human immune cells.

Authors:  Shyretha Brown; Shahin Tehrani; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2016-05-17       Impact factor: 3.446

9.  Fibrinogen drives dystrophic muscle fibrosis via a TGFbeta/alternative macrophage activation pathway.

Authors:  Berta Vidal; Antonio L Serrano; Marc Tjwa; Mònica Suelves; Esther Ardite; Roberta De Mori; Bernat Baeza-Raja; María Martínez de Lagrán; Peggy Lafuste; Vanessa Ruiz-Bonilla; Mercè Jardí; Romain Gherardi; Christo Christov; Mara Dierssen; Peter Carmeliet; Jay L Degen; Mieke Dewerchin; Pura Muñoz-Cánoves
Journal:  Genes Dev       Date:  2008-07-01       Impact factor: 11.361

10.  Fibrin depletion decreases inflammation and delays the onset of demyelination in a tumor necrosis factor transgenic mouse model for multiple sclerosis.

Authors:  Katerina Akassoglou; Ryan A Adams; Jan Bauer; Peter Mercado; Vivian Tseveleki; Hans Lassmann; Lesley Probert; Sidney Strickland
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.